Searched for
DRUG PRICING IN INDIA
Rs 78,400 vs Rs 7,750 medicine: Novartis, Eli Lilly oppose bid to cut breast cancer drug prices in IndiaNovartis and Eli Lilly have opposed a Kerala High Court petition seeking government intervention to make two breast cancer drugs cheaper, d...- These mid-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of over 25%, according to analystsThere are times when a watchlist is more important than a buy list. But if you still insist on putting money in the market, look at fundame...
- Zydus gearing up for next phase of growth, eyeing new areas: Sharvil Patel, MD"From 2030 and beyond, we will see strong earnings from pure discovery-led business, which is our central business, our oncology business a...
- GLP-1 drugs, AI shopping to drive food consumption, says Magnum CEO Peter ter KulveGLP-1 drugs and AI shopping will drive future food consumption globally. India, China, and the US are already experiencing these significan...
- 'Inflated medicine prices are daylight robbery': SC pulls up pharma companies over huge MRP-PTR gapSupreme Court on Tuesday questioned the wide gap between the price to retailer and MRP of some cancer medicines, calling inflated pricing a...
- 'The Paradise' sets records for Nani: Special shows for public ahead of release. Checking timings and ticket pricesTelugu star Nani’s much-anticipated film The Paradise will arrive in the theatres on September 24, 2026. Ahead of its theatrical debut, Tel...
- MF Tracker: HDFC Pharma & Healthcare Fund tops equity MFs at 25% in 1 year. Should investors chase the rally?HDFC Pharma and Healthcare Fund recorded an impressive 25% return in the last year, surpassing its category average across various time fra...
- Wegovy maker Novo Nordisk faces investor pressure to find growth beyond weight-loss drugsFacing increased scrutiny, Novo Nordisk must clarify its future strategy outside of its leading weight-loss drug. Investors are advocating ...
- 100% US tariff law raises uncertainty, may disrupt India's exports if imposed: ExportersA new United States law could impose steep tariffs on Indian goods. This legislation creates significant uncertainty for bilateral trade re...
- Takeda partners Dr Reddy's to launch dengue vaccine Qdenga in India from 2027Takeda and Dr. Reddy's Labs will promote the Qdenga dengue vaccine in India. This pioneering vaccine is expected to launch in the first hal...
- ETSA winner Theranautilus heads to human trials; JSW One’s IPO plansHappy Friday! Theranautilus is set to begin human trials of its nanorobot-based dental tech soon. This and more in today’s ETtech Morning D...
- Advent inks pact with Yatharth Hospital to invest Rs 3,150 crore for 24.9% stakePromoters Ajay Kumar Tyagi and family and Kapil Kumar currently hold 55.8% stake in Yatharth; public shareholders own the remainder.
- These mid-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of over 25%, according to analystsAs an investor, what you need to do at this point of time is this: A bit of extra work in terms of stock-picking so that you avoid anxiety ...
- Rs 11 IV for Rs 325, Rs 6 syringe for Rs 57: Tukaram Mundhe flags 2,841% inflated hospital bills that patients don't even know, sends recommendation to CentreMaharashtra FDA Commissioner Tukaram Mundhe has cited a survey showing substantial differences between procurement prices and printed MRPs ...
- Stocks in news: Yes Bank, Vedanta, Groww, BHEL, Bharat Forge and NBCCIndian equity markets closed lower on Tuesday, extending their monthly decline. Nifty50 reached a key support level, indicating a potential...
- Short-term headwind? Yes. But the structure stays intact: 5 large-cap stocks with upside potential of up to 19%Wise men on the street will tell you it is foolish to try and time the market. And attempting to do so in the midst of a raging war is prob...
- Stocks in news: Tata Group stocks, HDFC Bank, Coforge, HFCL, Sun Pharma and Varun BeveragesOn September 11, Indian stock markets experienced a remarkable bounce back after an initial dip at opening. Key index heavyweights attracte...
- India’s food safety rules are giving restaurants heartburn: It’s the process, not just the productIndia’s food safety regime has shifted from testing adulteration in the final product to policing the processes that prevent it. Restaurant...
- Swiggy launches dedicated food safety helpline, in-app channel for customers to report order-related concernsSwiggy has introduced a dedicated helpline and an in-app channel for food safety concerns. Customers can now report issues by calling a spe...
- Drug cos refuse to take sole responsibility for overpricingIndian drugmakers oppose a proposal making them solely liable for medicine overpricing. This regulatory move exempts retail chemists, hospi...
Load More
